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ABSTRACT 
N-LINKED GLYCANS CHARACTERIZAION AND BIOMARKER 
DISCOVERY BY SEQUENTIAL MASS SPECTROMETRY 
by 
Hongqih (Jenny) Jiao 
University of New Hampshire, September 2009 
N-linked glycans from a well-studied glycoprotein, (hen albumin) were 
characterized using ion trap MS (MSn) without chromatographic separation. From 
the spectral profile, ten major ion compositions were selected for study, which 
resulted in the characterization of 37 isomeric structures, 16 of which were 
previously unreported. These findings were compared with previously reported 
studies using different analytical strategies: IMMS, MS/MS. MSn not only 
identifies but also structurally characterizes components in the absence of any 
adjunct instrumentation. Selected examples have been detailed. 
A major challenge for adult stem cell (ASC) research is the lack of specific 
biomarkers for their identification and isolation. In this study, carbohydrates were 
evaluated as candidate biomarkers that mimic the defining property of ASCs, 
asymmetric self-renewal. Composition differences, ASC-specific structures and 
the distribution of structural branching patterns were discovered as ASC-specific 





1.1 Glvcans and Glycoproteins 
Three major classes of biomolecules are required for a living cell: proteins, 
nucleic acids and carbohydrates1. From DNA to RNA to protein, the gene-
template-based synthesis and relatively simple linear connection make protein 
study fairly straightforward and successful. However, proteins alone can not 
account for much the biological complexity and it is the post-translated 
modifications (PTM) that provide diversity of organisms. A more complete 
account of biological function must consider the major roles played by 
glycoconjugates, e.g., glycoprotein and glycolipids. 
Glycoproteins are glycoconjugates in which oligosaccharide chains (called 
glycans) are covalently attached to a protein. The glycans are frequently present 
on the outer surface of the cell and can be easily recognized by other cells or 
organisms. The attached glycans influence biosynthesis, stability, function and 
turnover of the conjugate protein. Also the glycans play significant roles 
themselves by using the protein as a platform for positioning2,3. 
In general, proteins exhibit two categories of glycans: N-glycans and O-
glycans. An N-glycan is a saccharide chain covalently linked by an N-glycosidic 
bond to asparagine. The most common N-glycosidic bond is acetylglucosamine 
- 1 -
(GlcNAc) connected to an asparagine amide residue of a protein with a 
consensus peptide sequence: Asn-X-Ser/Thr (X can be any amino acid except 
proline). All N-glycans share a common pentasaccharide core: Mancrt-
6(Mana1-3)Manp1^GlcNAcp1-4GlcNAcp1-Asn-X-Ser/Thr. An O-linked glycan 
is covalently bounded by an O-glycosidic bond from N-acetylgalactosamine 
(GalNAc) to the hydroxyl group of serine or threonine. Instead of one common 
core for N-glycans, there are a series of core structural classes for O-glycans2. 
1.2 N-qlvcans 
It is estimated that at least 
50% of human proteins are N-
O Man 
glycosylated4. N-glycans can be Q 
classified into three groups: high-
mannose, hybrid and complex, 
which are summarized in Figure 
1.1. 
GlcNAc I Gal NeuAc 
Asn 
High-Mannose 
Figure 1.1 Common Types of N-glycans 
N-glvcans Biosynthesis 
Biosynthesis of eukaryotic N-glycan starts from the endoplasmic reticulum 
(ER) and finishes in the Golgi apparatus. Compositional and functional diversity 
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of glycan residues is a distinguishing characteristic of protein glycosylation, which 
is a consequence of glycosidases and glycosyltransferases5. Assembly of N-
glycans occurs mainly in four phases: (1) formation of Dolichol-P-P-Glycan 
precursor — lipid-linked oligosaccharide (LLO); (2) transfer oligosaccharide to 
proteins; (3) sugar residues early trimming process; (4) maturation of the 
glycans. The first two phases have been conserved in all eukaryotic cells. 
However, the extent of trimming and maturation shows loose genetic 
relationship6. 
Glycans are synthesized by a series of glycosyltransferases and degraded 
by glycosidases. The glycosidases and glycosyltransferase are regulated by 
gene expression and define a sequence quantity probability but not the exacting 
sequence. The product of one enzyme reaction can be a preferred substrate for 
another enzyme. This sequential mechanism can also be substituted by 
branching. The availability of sugars, the acceptor substrates, the competition 
among enzymes, the pH levels, the micro environment and so on, all participate 
in the regulation of a glycan's assembly2,7. 
Heterogeneity of N-glvcoproteins and N-qlvcans 
Glycoproteins can be highly heterogeneous in several aspects: First, the 
protein sequence and conformation can cause N-glycoprotein diversity by 
affecting substrate enzyme affinity. Secondly, glycan-specific sites can be 
another reason of heterogeneity. If there are more than one sequon of Asn-X-
- 3 -
Ser/Thr on the protein, each sequon could produce a subset of glycans (called 
glycoforms), and hence glycoproteins. A sequon is only a potential glycosylation 
site of N-glycans, glycosylation depends on many other factors. Thirdly, 
glycoforms on a specific site dramatically enlarge the glycoprotein. The glycans 
are not directly encoded by the genome and their variable structures are highly 
diversified. Therefore, one protein when glycosylated may exhibit a large 
heterogeneous pool. 
The diversity of N-glycans can be initiated at the monomer level. At least 
ten monomers are recognized, and the number is growing. D-xylose (Xyl), D-
glucose (Glc), D-galactose (Gal), and D-mannose (Man), A/-acetyl-D-
glucosamine (GlcNAc) and A/-acetyl-D-galactosamine (GalNAc), L-fucose (Fuc), 
D-glucuronic acid (GIcA) and L-iduronic acid (IdoA), A/-acetylneuraminic acid N-
glycolylneuraminic acid are found in the cells of "higher" animals. Also, each 
monomer may exhibit modifications, such as esterification, acetylation and 
methylation on different positions, making the glycan pool even larger. The 
linkage between monosaccharides may be stereocally different referred to as 
anomeric types (a or (3). In addition, each monomer can form glycosidic bonds 
with other monomers, referred to as branching, a common feature of 
glycosylation. 
Importance of N-linked Glycosylation 
A single protein can give rise to numerous glycoproteins, which may 
function in variable ways in tissues. In vivo studies have indicated that changes 
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of sialylation and branching can affect erythropoietin (EPO)'s stability, half-life, 
and activity. N-linked glycosylation functions can be probed by using inhibitors of 
glycosylation, or gene mutations 8'9. During disease states glycan profile patterns 
are known to change. This new pattern may affect the biological activity with 
potential adverse consequences. Therefore, these studies not only provide an 
understanding of glycan structure, but also reveal that certain 
glycosyltransferases may be targets for effecting diseases therapeutics10"12. 
N-glycosylation controls of glycoprotein folding. The consequences of 
altered glycosylation can be devastating13. Many N-glycan structural differences 
have been reported to be related to the process of preparing cell specific 
structures12' 13. To identify the biological consequences of glycosylation, a 
complete glycan structural characterization is required. Because of the 
complexity, this has been a challenging endeavor. 
1.3 Analytical tools for qlvcan structures 
A variety of analytical technologies have been developed for 
characterizing carbohydrate structures. NMR has been considered as the most 
comprehensive tool for de novo glycan characterization. However, the instrument 
sensitivity, molecular weight limitations, the requirement of relatively pure sample 
amounts, and spectra interpretation complexity make the practical applications of 
NMR quite limited14. Various chromatographic and electrophoretic techniques 
- 5 -
have also been utilized for the separation and identification of glycans15"18. 
Because of their high sensitivity, simplicity and specificity, mass spectrometry-
based methods have gained popularity in characterizing glycan structures. 
Tandem Mass Spectrometry (MS/MS) 
Due to its great success in the field of proteomics, MS/MS based 
approaches have attracted much attention in the analytical glycomics field. 
Researchers have applied the protocols directly from proteomics. By using 
software tools to correlate glycan MS/MS fragment spectra to a database, one 
can identify a plausible structure. Nevertheless, the MS/MS spectra are 
inadequate to define the exacting details of a carbohydrate structure. The MS/MS 
based methods have multiple problems differentiating glycan structures. But 
clearly, an MS/MS spectrum can not contain adequate information to assign a 
glycan structure unambiguously19. 
Ion Trap Sequential Mass Spectrometry (MSn) 
In an attempt to overcome the limitations outlined above, an ion trap MSn 
approach has been developed in the Reinhold lab at University of New 
Hampshire for the past several years and more recently, integrated with software 
tools to handle the plethora of data 20"23. With an ion trap instrument, MSn allows 
molecules to be disassembled sequentially: selected precursor ions are isolated 
in the gas phase and further fragmented. The multiple step precursor-product 
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relationships (MSn pathways) define components of structure. By re-tracing the 
pathway, the topology can be defined by using simple logical reasoning. 
A common work flow is outlined in Figure 2.1 in chapter II. Two distinct 
stages are involved during the process: (1) Determination of isomeric topology; 
and (2) Identification of inter-residue linkages. By selecting signature ions at each 
step, the product spectra provide information for major glycan topology 
determination. Abundant ions that fail to account for the perceived structures 
indicate the presence of additional isomers. These aberrant ions are then 
selected for further study23. Once the major topologies are determined, the 
linkage information can be characterized by looking for cross-ring cleavage 
fragments, and spectral matching in the fregment library21. 
Importance of Sample Derivatization 
Derivatization has been the mainstay of oligosaccharide structural 
investigation. Methylation24 is an effective way of blocking the hydroxyl groups to 
position monomer fragments in a glycan array and additionally eases the cleanup 
process by lipophilic extraction. Methylation also enhances ion signals. In 
summary, permethylation is an important component for carbohydrate structure 
determination. 20 
Brief Overview of the Thesis Topics 
In this thesis, two biological application examples are described in the chapter 
II and III to exemplify our overall strategy for glycan structural characterization 
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using the MS" technology. The two examples address the typical challenges 
facing glycoprotein analysts, including how to resolve glycan isomeric structure 
within one real biological sample (Chapter II: Isomer Characterization of N-linked 
Glycans from Chicken Ovalbumin by Ion Trap MS"), and how to perform the 
comprehensive multiple sample comparison analysis in order to identify potential 
glycan biomarkers (Chapter III: Glycan Biomarker Discovery of Adult Stem Cells 
Using Sequential Mass Spectrometry). 
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CHAPTER II 
ISOMER CHARACTERIZATION OF N-LINKED GLYCANS 
FROM CHICKEN OVALBUMIN BY ION TRAP MS 
2.1 Introduction 
The diversity of glycan biological roles has been studied for decades. 
Variations have been found with development, differentiation, malignancy, and 
phylogeny of animals. However, glycan structural characterization has been a 
formidable analytical task hindering biomedical research. An integrated 
analytical/computational strategy based on ion trap MSn technology has been 
under development in the Reinhold lab in the past several years to attack this 
challenging problem. This chapter contrasts the results from this method with the 
reported findings of other laboratories using a widely accepted biological 
reference standard, the N-glycans from chicken ovalbumin. 
Chicken ovalbumin comprises 60 - 65% of the total protein in egg white 
and is one of the first proteins isolated in a pure form25. It was defined as a 
glycoprotein more than seventy years ago26. At least thirty glycan compositions 
have been detected from chicken ovalbumin on its single glycosylation site. The 
different glycoforms share a common core structure: Mana1-6(Mana1-3)Manp-
4GlcNAc(31-4GlcNAc -Asn29327"30. Chicken ovalbumin has been used as a 
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standard glycoprotein for the purpose of new analytical methods development 
and validation for decades. 
2.2 Experimental Methods 
N-linked glvcans release 
Chicken egg ovalbumin (grade V) was obtained from Sigma-Aldrich (St. 
Louis, MO). Peptide-N-glycosidase F (PNGase F) deglycosylation kits were 
purchased from New England Biolabs Inc. (Ipswich, MA). 1 mg ovalbumin was 
dissolved in 100 uL of 1X denaturing buffer (10uL denaturing buffer 10x 
concentrated with 90 pL HPLC water) and denatured by heating at 98°C for 20 
minutes. The sample was cooled to room temperature and to it was added 10uL 
10X G7 buffer (0.5 M sodium phosphate, pH=7.5), 10 uL NP-40, and 3uL 
PNGase F enzyme. Sample was vortexed (-10 seconds), centrifuged for 1 
minute and then placed in an oven (37°C) for overnight incubation. 
N-linked glvcan separation 
The enzymatically released N-linked glycan solution was dissolved in 5% 
(v/v) HPLC grade Acetonitrile (ACN), 95% (v/v) HPLC grade water, and 0.1% 
trifluoroacetic acid (TFA). Proteins were removed by solid phase extraction with a 
C18 column (SPE) (Alltech Associates, Deerfield, IL). The column was pre-
wetted with 5 mL of the following solutions in the sequence: (1) 100% HPLC 
- 1 0 -
grade methanol; and (2) A solution of 5% (v/v) HPLC grade ACN, 95% (v/v) 
HPLC grade water and 0.1% TFA. Then, the sample was loaded onto the column 
and washed with 5 ml_ of 5% (v/v) HPLC grade ACN, 95% (v/v) HPLC grade 
water and 0.1% TFA. The eluent was immediately collected and dried in a 
SpeedVac concentrator (Savant Instruments, Holbrook, NY). 
N-linked glycan purification 
A porous graphitized carbon (PGC) retentive solid phase extraction 
column was used for additional purification and desalting of the N-linked glycan 
sample. The column was prepared with the procedure as described 32 with slight 
modifications. Dry PGC (Carbograph 120/400, Alltech Associates, Deerfield, IL) 
was washed three times with 4 mL of the following solutions: (1) 1M sodium 
hydroxide; (2) HPLC grade water; (3) 80% aqueous acetonitrile (ACN) with 
0.1%Trifluoroacetile acid(TFA); (4) 25% aqueous ACN with 0.05%TFA; (5) 25% 
aqueous ACN; (6) HPLC grade water. The tube was vortexed, centrifuged and 
the supernatant was removed from each washing. The prepared PGC was 
loaded to a 1.5 mL reservoir column and conditioned with 3 mL HPLC grade 
water. Dried glycan sample was dissolved in 1 mL HPLC water and loaded onto 
the column. Salts were removed by 5 mL water wash and neutral glycans were 
collected by elution with 1 mL 25% (v/v) acetonitrile aqueous solution 5 times. 
The 5 mL eluent was dried in a SpeedVac concentrator. 
- 1 1 -
N-linked glvcan reduction 
N-glycans were reduced to alditols with a 500 uL solution of sodium 
borohydride (NaBH4) (10mg/ml_ in 0.01 M NaOH) and sitting for 1 hour in ice 
followed by leaving overnight at room temperature. The reaction was terminated 
by drop-wise addition of glacial acetic acid. Sample was diluted with 3ml_ 
ethanol and dried with a stream of nitrogen. Borates were removed by 
esterification with methanol sequentially adding and drying 3mL of 1% acetic acid 
methanol solution 3 times and then by 3mL of toluene for 3 times. Dried samples 
were dissolved in water and desalted on a DOWEX AG 50 W X8-400 cation-
exchange resin (Sigma-Aldrich, St. Louis, MO). The resin was washed by 5 mL 
HPLC grade water 10 times and loaded into a 1.5 mL reservoir. Glycans were 
eluted by 5mL water and dried with SpeedVac. 
N-linked glvcan permethvlation 
Permethylation24 was carried out by dissolving the dried sample in 500 uL 
dimethyl sulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO). Sodium hydroxide 
powder (99.99%) was added to the glycan-DMSO solution. After 30 minutes of 
vortexing, to produce a suspension, 100 uL of methyl iodide was added to 
perform the permethylation. The reaction tube was wrapped with parafilm and 
aluminum foil, and then vortexed for 1 hour. Two milliliters of water was added to 
the reaction tube in ice bath to terminate the reaction. Permethylated glycans 
were extracted three times with 1 mL of dichloromethane (HPLC grade, Fisher 
Scientific, Fair Lawn, NJ). The extract was washed 5 times with 2 mL of HPLC 
- 1 2 -
water. The methylated glycans were dried under nitrogen stream, and analyzed 
by MS. 
MALPI-TOF Mass Spectrometry 
Released, reduced and permethylated glycans were analyzed with a 
MALDI-CFR mass spectrometer (Krotos-Shimadzu Analytical, Manchester, UK) 
equipped with an ultraviolet 337 nm wavelength nitrogen laser. For native and 
reduced glycans, the sample was dissolved in 100 uL of HPLC grade water, and 
for permethylated samples, 75% methanol aqueous solution was used. One uL 
of sample was spotted on the MALDI target plate with 1 uL of 2, 5-dihydroxy 
benzoic acid matrix (DHB) (10 mg/mL in 50% (v/v) acetonitrile aqueous solution). 
After drying, 0.4 uL ethanol (HPLC grade) was applied to the spot for constant 
signal. Parameters (such as: power, shots accumulated per profile, optimized 
mass number) were set according to set protocols. Spectra were processed by 
Kratos Lauchpad software. 
ESI Mass Spectrometry 
MSn mass spectra were obtained with a LTQ mass spectrometer (Thermo 
Fisher Scientific, Waltham, MA) equipped with a TriVersa Nanomate (Advion) 
automated ion source. Samples were infused at flow rates ranging from 0.30 to 
0.60 uL/min, and spectra were collected by using Xcalibur 1.4 and 2.0# software 
(Thermo Fisher Scientific). Signal averaging was accomplished by 5 micro-scans 
within each scan and adjusted 50 to 300 scans in each spectrum according to 
- 1 3 -
the level of signal to noise. This improved the spectral quality and was 
necessary at the higher orders of MSn due to diminishing signal, particularly 
beyond MS5 or MS6. Collision parameters were left at default values with 
normalized collision energy set to 35% or to a value leaving a minimal precursor 
ion peak. Activation Q was set at 0.25 and activation time for 30 ms. Changing 
collision energy did not affect the relative abundance of product ions, but change 
the precursor ion abundance. The Activation Q and activation time were kept 
constant since they can affect the product ion abundances20. 
Data Analysis 
In-house bioinformatics tools (Glycoscreen, CompositionFinder al et) 
developed by Hailong Zhang were used to assist data analysis. A schematic flow 
process used to determine structures of N-glycans has been outlined, (Fig. 2.1). 
Initially, the ion compositions of N-glycans were assigned using Glycoscreen. 
Then, selected ions from each MS" spectrum were considered to determine 
topologies. During this process, each spectrum was carefully examined to ensure 
that there no conflicting ions. If there were, then these aberrant ions were 
selected resolve the different topologies. Once the topologies were resolved, the 
characteristic fragments resulting from cross-ring cleavages within small 
oligomers were compared with fragment library standards to help define linkages. 
- 1 4 -
Sample preparation 















Figure 2.1 The flow process to determine structures. 
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2.3 Results and Discussion 
MS profile and N-glvcan compositions 
The ESI MS profile (Fig. 2.2) is a spectrum of the reduced, methylated N-
glycans from chicken ovalbumin with the 10 most abundant ions labeled with m/z 
values and their corresponding compositions. The N-glycans share a common 
core of Mana1-6(Mana1-3)Man|3-4GlcNAc31-4GlcNAc. The compositions of the 
10 most abundant ions in MS profile are: H3N2, H4N2, H3N3, H5N2, H4N3, 
H3N4, H6N2, H5N3, H4N4 and H3N5. H indicates hexose and N indicates 
HexNAc. These compositions were selected for MSn analysis. 
Ovalbumin 
N-glycans 
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Figure 2.2 The ESI MS profile of N-linked glycans from chicken ovalbumin with 
the 10 most abundant ions labeled with m/z values and their corresponding 
compositions (H: Hexose; N: HexNAc). 
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Isomer characterization using sequential mass spectrometry 
In total, 36 N-glycan isomers have been identified within the 10 selected 
compositions. 15 of which were structures previously unreported. The complete list 
of isomers and supporting evidence has been compiled in Appendix. Due to the 
large volume of information and the thesis page limit, only a few selected examples 
are presented in the following sections to exemplify the general procedures and 


































































Table 2.1: The overall comparison of the N-glycans isomers identified from chicken 
ovalbumin using different analytical techniques. Reference: Clemmer et al. * (2008); 
Reference: Lattova and Perreault ** (2004); Harvey et al. ** (2000). 
The overall comparison of the isomers from chicken ovalbumin using 
different analytical techniques*19, #31 is shown in Table 2.1. In general, the 
sequential mass spectrometry-based approach provides a more comprehensive 
- 1 7 -
evaluation of isomers than either IMS/MS (ion mobility mass spectrometry) or 
MS/MS methods. The nomenclature of carbohydrate fragmentation are shown in 
Figure 2.333. 
/ / / / / / / / / 
2.5A, B, C, 2.4AJ B^ C-, O ^ B3 C3 
Figure 2.3 Nomenclature for carbohydrate fragments. This figure is modified from 
Domon and Costello (1988). 
2.3.1 The Topology Determination of H3N4 fm/z 1677) 
The process of determining topology for the ion composition H3N4 (m/z 
1677) is detailed to demonstrate the approach to resolving isomers. The 
diagnostic MSn pathways and the determined isomer structures are summarized 
(Table 2.2), along with the corresponding glycan fragments pathways. 
Isomeric structures D, E and F were previously reported. Structure D and 
E are reported by Lattova et al31 (MS/MS), while structure E and F are reported 
by Harvey28 using multiple techniques (mainly NMR). In this thesis study, 
structure D was found after linkage elucidation of topology A; isomeric structure 
E and F were detected after linkage characterization of topology B. The fourth 
isomeric structure G was revealed after the linkage elucidation of topology C. 
- 1 8 -
Unlike structure D, E or F which has one HexNAc attached to the core mannose, 
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Table 2.2 H3N4 isomers determined by MS". 
Generally, fragments can be classified into two groups: glycosidic bond 
cleavages and cross-ring cleavages34. Glycosidic cleavage occurs between two 
monomers, which may yield B-, C-, Y- or Z- type ions. A cross-ring cleavage 
ruptures two bonds in a monomer, which gives A- and X- type ions. Glycosidic 
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bond cleavages define a glycan's topology, while cross-ring cleavages are 
essential in determining of inter-residue linkages. The number of glycosidic 
bonds in each ion composition provides a clue of other associated residues. For 
a permethylated sample, glycosidic bond cleavages provide specific pyranosyl-1-
ene (B- and Z-type ions) or open hydroxyl (Y- and C-type ions) that would be 
products of the ruptured bond. These cleavage identifiers are defined as "scars". 
By selecting compositions rich in such information, monomers can be positioned 
in a topology array. 
As an example, to elucidate the topology of H3N4, the ion with m/z 1677.6 
was selected for MS2 analysis (Fig. 2.2). A product ion (m/z 1384.5) was the 
fragment residue H3N3 with one scar. This can be explained by a neutral loss of 
reduced terminal HexNAc (293u) leaving one scar on the product ion. By 
selecting that fragment (m/z 1384.5) for MS3, a dominant ion (m/z 1125.4) was 
observed fitting the composition H3N2 with two scars. Similarly, an informative 
ion from each spectrum can be selected; (pathway 1: m/z 1677 -> 1384 -> 1125 
-» 866 -» 662 -> 458 -> 268). Considering the known N-glycan core structure, 






.268 S> ^ 2 6 8 ^ C_268_ 
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Figure 2.4: The pathways to determine the topology structures of H3N4 (m/z 1677). 
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Figure 2.5: Topology A of H3N4: 1677 ^ 1384 ^ 1125 -» 866 ^ 662 -» 458 -» 268. 
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The ion abundance is not the only factor considered in parent ion 
selection, composition that includes monomers and scars is another, e.c. 
structural information is another. Ion fragments inconsistent with a single 
structure are indicators of isomers. Such ions in the ion trap can be further 
isolated, activated (CID) and disassembled, (Fig. 2.6). The ion with m/z of 662.3 
(Fig. 2.5) represents a major structure. The ion m/z 648.3 in the same spectrum 
represents the neutral loss of a fully methylated hexose inconsistent with that 
proposed structure. To examine this ion, pathway 2 was chosen m/z 866 -> 648 
-> 444-> 268. By reevaluating the pathway, it was clear another topology was 
determined, (Fig. 2.7). 
Figure 2.8 shows another spectrum with the presence of isomeric ions. 
The ion of m/z 444 in MS6 suggests Topology B (Table 2.2) of H3N4 in MS5, but 
the ion with m/z of 458 in MS6 indicates an additional isomer. To examine this 
ion, pathway 3 was selected, m/z 648 (neutral loss: one-scar H; 218u) -> 458 
(neutral loss: three-scar H; 190u) -> 268 (a two-scar N charged with Na+) (neutral 
loss: three-scar H; 190u) was executed. Figure 2.9 shows the topology of H3N4 
(Topology C) determined from this pathway. 
-22-
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Figure 2.6: A spectrum with the presence of conflicted ions. The ion with m/z of 662.3 





Figure 2.7: Topology B of H3N4: 1677 ^ 1384 ^ 1125 ^ 866 -» 648 -» 444 -> 268. 
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Figure 2.8: A spectrum with ion indicates the existence of the conflicted structure. The 
ion with m/z of 444.2 represents Topology B of H3N4. The ion with m/z of 458.2 
represents a new structure. 










Figure 2.9: Topology C of H3N4: 1677 -> 1384 -> 1125 -> 866 -> 648 -» 458 -» 268. 
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From MS2 to MS4 spectra, the topology A of H3N4 (Table 2.2) is 
suggested by the dominant ion m/z 662 and m/z 458. The topology B can be 
determined by the relatively less abundant ion m/z 648 and m/z 444. However, 
topology C was not revealed until MS6 by the fragmentation of ion m/z 648. 
2.3.2 The Structural Linkage Characterization of H4N2 (m/z 1391) 
The composition H4N2 has been selected to explain aspects of structural 
linkage elucidation. Three isomeric structures have been revealed in the study of 
this composition, Table 2.3. 
Figure 2.10: Topology and pathways of H4N2 with ambiguous linkages. 
- 2 5 -
The Topology determination pathway is shown in Fig. 2.10. The position and 
linkage of the terminal hexose (non-core hexose) are unspecified. To determine 
the topology, the pathway of ion with m/z 1391: (H4N2) -> 1098 (neutral loss: 
one-scar R; 293u) -> 880 (neutral loss: one-scar H; 218u) -> 635 (neutral loss: 
two-scar N; 245u) -> 463 (a one-scar C2-ion; charged with Na+) (neutral loss: 
three-scar H; 172u) was followed. 
Fragments from glycosidic bond and cross-ring cleavages are both used 
for the linkages characterization. Figure 2.11 and Figure 2.12 show the 
procedure of how linkages of H4N2 were characterized. Based on the common 
core sequence of Mana1-6(Mana1-3)Manp-4GlcNAc(31-4GlcNAc of N-glycans, it 
is important to find a characteristic cross-ring cleavage ion in order to determine 
the position of outer hexose on the core Mana1-6Man arm or Mana1-3Man arm. 
Ions from specific cross-ring cleavages act as an indicator of linkage position34. 
No apparent ion corresponding to a specific linkage was observed in MS2 or MS3 
spectra (Figure 2.11a and b). However, cross-ring fragments increased upon 
MS4 (Fig. 2.11c) providing direct indication of disaccharide linkage. According to 
previously determined topology, all these cross-ring fragments should come from 
the inner core Mannose ring rupture linked with a terminal dimer (H2 with 1 scar). 
In other words, ions with m/z of 505.3, 533.3, 547.3 and 561.3 are °'4A3-ion, 3,5A3-
ion, 3'5X2-ion and 2,4A3-ion, respectively. These ions were further disassembled 
and processed for MS5. 
Dominant ions with m/z 463 in each MS5 spectrum confirmed the existence of 
terminal dimer. However, dimers generated by cross-ring cleavages can be 
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linked to either arm of the core structure, namely, Mana(1-6)Man arm or Mana(1-
3)Man. Ions with m/z 547 and m/z 533 were selected as diagnostic ions to further 
detail linkages. 
The ion with m/z of 547.3 is a 3,5X2-ion coupled with a B-type ion, and 
fragment from the structure specific for defining 1-3 linked antennae. By 
disassembling this X2-B2-ion, the structure of non-core hexose located on the 
Mana1-3Man arm is unveiled by m/z 463.2 (one-scar C2-ion) and m/z 445.2 
(one-scar B2-ion) in MS5 (Fig. 2.11d). Since dominant glycosidic cleavage and 
weak cross-ring cleavage ions exist in MS5 spectrum, the linkage between the 
outer hexose and Mana1-3Man core is still not known. The fragmentation C2-ions 
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Figure 2.11: H4N2 structural linkages characterization (1-3 arm). 
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For linkage characterization, usually a B-ion spectrum can provide more 
information than that of a C-ion. Therefore, instead of dominant C2-ion, the B2-ion 
in MS6 was selected for further disassembly. The dominant peak m/z 371 (Fig. 
2.11e) indicates the terminal hexose is not present as the linkage of 1-6. The 
presence of relatively abundant ion with m/z of 299, which is a major cross-ring 
cleavage 2,5Xrion, indicates that the hexose is 1-2 linked to the core Mana(1-
3)Man arm. This ion can only be produced by terminal hexose1-2 linkage (Figure 
2.11e). 
In MS4, the ion with m/z of 533.3 (3,5A3-ion) is inconsistent with the 
structure of non-core hexose located on the core Mana(1-3)Man arm (Fig. 2.11 d 
to f), but fits the structure of Fig. 2.12a. The 3,5A3-ion of m/z 533.3 indicates that 
the non-core hexose is located on the core Man a(1-6)Man arm. The 3,5A3 ion 
m/z 533.3 was therefore selected for MS5. The C2-ion m/z 463.2 and B2-ion m/z 
445.1 in MS5 indicate the existence of the outer Hexose linked to the Man a(1-
6)Man arm (Fig. 2.12b). To identify the linkage of the hexose with core Mana(1-
6)Man, the B2-ion was selected for MS6. In the MS6 spectrum (Fig. 2.12c), the 
dominant cleavage of m/z 371, a 0,4Xi-ion, indicates the absence of any 1-6 
linkage between monomers. A major peak of m/z 343, a 3,5Xrion, could come 
from the structure with 1-2/3 linkage. By comparing the spectrum in Figure 2.11e, 
a 1-2 linkage specific ion m/z 299 does not exist in Figure 2.12c. It is believed 
that a structure with 1-3 linkage should be a major linkage, (Fig. 2.12d). 
Moreover, the cross-ring cleavage m/z 329 shows the presence of the linkage 1-
4/6, which conflicts to the 1-3 linkage structure. Even though at a relatively low 
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abundance, the peak of m/z 301 still indicates 1-6 linkage structure, and it is 
believed that Structure 3 exists (Figure 2.12d). 
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Figure 2.12 Structural linkage characterization for the 1-6 arm branched composition 
H4N2. 
In this way, a total of 3 isomers were identified for H4N2. The isomeric 
Structure 1 of H4N2 has an outer hexose 1-2 linkage to Man a(1-3)Man arm of 
N-glyan core. The isomeric Structure 2 of H4N2 has an outer hexose 1-3 linkage 
30-
to Man a(1-6)Man arm of N-glyan core. The isomeric Structure 3 of H4N2 has an 
outer hexose 1-6 linkage to Man a(1-6)Man arm of N-glyan core. Table 2.3 lists 
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Table 2.3 Structural linkages of H4N2 and their pathways determined by MSn. 
2.3.3 Structure Confirmation using Library Matching: H5N3 fm/z 1840. 8) 
MSn spectra of carbohydrate samples can be utilized as an exacting 
structure fingerprint. Structural details, including monomer identification, 
branching, linkage and stereochemical features can be determined by a 
combination of glycan disassembly and spectral matching of the products. The 
library (FragLib) has been generated from commercial samples (small oligomers) 
and those prepared from well-characterized glycoproteins. In this study, the 
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spectral library matching method has been used for the determination of 
carbohydrate substructures. 
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Figure 2.13 The substructure determination of one of the H5N3 isomers using 
FragLib. A: the comparison of the standard spectra (A-1: branched H3 and A-2: 
linear) and the MS4 spectrum 1840 -» 1547 -» 667 of H5N3 (A-3); B: the 
comparison of the standard spectrum (B-2) and the MS5 spectrum 1840 -> 1547 -> 






Figure 2.14 A full structural linkage of H5N3 Topology revealed by MS" and library 
matching. 
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Figure 2.13 illustrates the process of substructure determination of one of 
the H5N3 isomers using FragLib. The MS4 spectrum (1840 -» 1547 -> 667) of 
H5N3 (Fig. 2.16 A-3), which corresponds to a composition as H3 plus one single 
scar, matches very well with the reference spectrum from the branched standard 
(Fig. 2.13 A-1), but shows no similarity to the spectrum from the linear standard 
(Fig. 2.13 A-2). The further comparison of the MS5 spectrum also confirms the 
results (Fig. 2.13 B). 
By using library matching, it is concluded that the fragment of m/z 667.3 from 
H5N3 has a single structure. This structure is the same as the tri-mannose part, 
Mana(1-6)Mana(1-3)Man, of N-glycan core. Fig. 2.14 shows a complete 
characterized structure after all separated fragments from the parent ion are 
regrouped. 
A Comparative Assessment: H5N3 (m/z 1840.8) 
For the composition H5N3 with m/z 1840.8, a total of 4 topologies were 
determined by MS" (Table 2.4). Two of them were reported previously (by NMR 
and MS/MS). They are also included in Table 2.4 for easy comparison. The two 
isomers defined by the diagnostic pathways of 1840 -> 1547 -> 1288 -> 1070 -> 
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Table 2.4 H5N3 isomers determined by MS". 
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(A) 
Isomer # 1 of H5N3 (m/z 1810.6) Isomer # 2 of H5N3 (m/z 1810.6) 
662', 662 — 
(B) 
Figure 2.15 The MS5 spectrum (1840 -» 1574 -> 921 -» 662) of H5N3 provides 
strong evidence to support the presence of the topology isomer #1, which is 
missing from the literature. (A) The ions m/z 444 and m/z 458 are the diagnostic 
ions of H5N3 isomeric structures #1 and #2 respectively. (B) The MS5 spectrum 
(1840 -> 1574 -» 921 -> 662) of H5N3 
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The MS5 spectrum (1840 -> 1574 ^ 921 -* 662) of H5N3 provides strong 
evidence to support the presence of the topology isomer #1, which is missing 
from the literature (Figure 2.15). The residue of m/z 662 is H2N1 with 3 scars. 
The ions with m/z 444 and m/z 458 are the structure-specific ions to the isomer # 
1 and Isomer #2 respectively. In the MS5 spectrum (Figure 2.15 B), the ion m/z 
444 (H1N1 with 4 scars) is much more abundant than the ion m/z 458 (H1N1 
with 3 scars). Therefore, our sequential mass spectrometry-based approach is 
capable to detect and resolve isomers which might be invisible to the others 
methods. 
2.3.4 H3N3 (m/z 1432) Linkage Characterization by Using Li* Adduction Ions 
For the same ten most abundant N-glycan compositions of chicken 
ovalbumin, MS/MS revealed a total of 18 isomers, IMS-MS revealed a total of 20 
isomers and MSn revealed a total of 36 isomers. Clearly, MSn is more capable of 
finding glycan isomers. However, for H3N3 composition, 3 isomers were 
detected by MS", compared with 4 isomers reported by IMS-MS. It is possible 
that the non-core HexNAc might have different linkages to the core part. During 
the MSn fragmentation process, the non core HexNAc residues are very easy to 
break down at the very early fragmentation stages. This presents a challenge to 
find out the linkage of N to the neighboring residue. 
To solve this problem, a special technique was explored in the structure 
study, e.g., changing adduction ions to fit special requirements. It is known that 
fragmentation yields are inversely related to the size of adduction cations 35. An 
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exploration of adduction ion Li+ in H3N3 was used to find out the linkage of non-
core HexNAc. For H3N3, most of the terminal HexNAcs lost in the step of MS3. 
To detect the HexNAc linkages, it is necessary to isolate and disassemble the N 
attached monosaccharide. Figure 2.19 compares MS6-MS8 spectra of H3N3 
obtained with Na+ and Li+ adduction ions, step by step. The spectra showed that 
Na+ ion is too "big" to be adducted by small monosaccharide. As a result, the 
spectrum of m/z 227 (pathway: 1432 ^ 1139 ^ 880 -* 662 -* 417 -> 343 -* 
227) is not detectable. However, when Li+ ions were used, the spectrum of m/z 
211 is very informative. It generates the first two structures of H3N3. 
By analyzing mono-residue m/z 211 (Bi-ion with Li+) MS8 spectrum 
(pathway: 1416 -* 1123 -» 864 -* 646 -* 401 -* 327 -^ 211), the fingerprint ion 
m/z 151 indicates a hydroxyl (a scar formed by the loss of HexNac earlier) on the 
6th position. This is the diagnostic peak for structure 1 shown in Figure 2.19. 
Meanwhile, the second dominant ion with m/z 109 discloses the fragments which 
might come from a hydroxyl at the 2nd or 3rd position. The ion of m/z 153 formed 
by a neutral loss of m/z 58 is relatively low in abundance (characterized by 2 
position hydroxyl). This indicates the presence of 1-2 structural linkage. 
This experiment shows that different metal adduct ions can be used 
under different circumstances. For small oligosaccharides structures 
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Figure 2.16: (A) An ambiguous topology of H3N3. (B) A step by step 
comparison of MS6 - MS spectra obtained with Na+ and Li+ adduction ions. 
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2.4 Conclusion 
The use of ion trap mass spectrometry precursor isolation coupling 
with sequential disassembly to determine the carbohydrate isomeric structures 
has been described. The presence of carbohydrate isomers has been less 
appreciated and frequently overlooked. The underlying structural isomers have 
highly similar structures with very similar physical and chemical properties. This 
makes it extremely difficult, if not impossible at all, to separate carbohydrate 
isomers using any types of chromatography. Additionally, because of the 
inherited limits, any other MS based methods without higher degree 
fragmentation are blind to the presence of many isomers, which are quite easy to 
be detected with our approach. This is clearly indicated by the comparison result 
of our findings and the previously reported structures. Our results strongly 
suggest that the preeminence of ion trap MS", coupled with the appropriate 
sample preparation methods and the sophisticated data acquisition/analysis 
techniques, makes it an ideal instrument for carbohydrate sequencing with 
minimum assumptions on the underlying structures required. 
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CHAPTER III 
GLYCAN BIOMARKER DISCOVERY OF ADULT STEM 
CELLS USING SEQUENTIAL MASS SPECTROMETRY 
3.1 Introduction 
Stem Cell. Adult Stem Cell, and Asymmetric Self-renewal 
Stem cells are unspecialized cells which can self-renew by cell division for 
a long time. Under selected environment, stem cells can be induced to form cells 
with specific functions, for example, develop into different types of cells, such as 
muscle, blood, and nerve cells. Such cells can be used to repair damaged 
tissues. Scientists have been trying to find a way to transplant stem cells to treat 
diseases and disorders36"38. 
In general, there are two types of stem cells: embryonic stem cells (ESCs) 
and adult stem cells (ASCs). ESCs are usually extracted from embryos with the 
potential of unlimited expansion and pluripotency (ability to differentiate into 
nearly all types of body cells). Ethical concerns and transplant rejection of ESCs 
are parts of the hurdles for researchers to deal with. ESCs have been proposed 
as promising candidates for future therapies. Nevertheless, after nearly ten years 
of research, there are still no approved treatments using embryonic stem cells39, 
40 
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On the other hand, adult stem cells, also called somatic stem cells, are 
found in differentiated cells in many organs and tissues. ASCs can differentiate to 
yield many types of specialized cells without ethical controversies and lower risk 
of transplant rejection. ASCs from different sources, including umbilical cord 
blood and bone marrow, have been clinically used in medical treatment for 
41 42 
years . 
Asymmetric self-renewal is the defining 
property of ASCs and it is essential for the 
maintenance of adult stem cell43. Following 
asymmetric cell self-renewal process, ASCs divide 
to yield one daughter cell, which is a long-lived cell 
identical to its parent cell, and another daughter 
cell called progenitor cell. The progenitor cell loses 
pluripotency and the asymmetric self-renewal 
attribute. Its further divide to generate specialized 
cells. 
Figure 3.1 Asymmetric 
ASCs self-renewal 
o -stem cells 
A -progenitor cell 
Poor History of ASCs Biomarkers Discovery 
ASC-specific biomarkers are invaluable in many research fields. Stem cell 
biologists need them to study ASC functions; cancer biologists want a way to 
evaluate the roles of ASCs as carcinogenic targets; pharmaceutical clinicians 
desire diagnostic and prognostic markers and indicators of drug-tissue 
interactions. 
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However, to date, no protein markers have been identified as tissue-
specific for ASC; and also no universal biomarkers have been established to 
differentiate ASCs from other tissues as well43. The difficulty has been due to a 
number of factors: Firstly, ASCs constitute only a small fraction of tissue cells, 
estimated to be less than one per several thousands in many tissues, even as 
low as 1/100.00044. Additionally, in culture, cell populations enriched for ASCs 
decline in purity rapidly. Finally, the defining morphological attributes of ASCs 
have remained undescribed. 
A New System for Studying ASCs 
In order to overcome the obstacles outlined above, the Sherley lab at 
Boston Biomedical Research Institution (BBRI) took a novel approach, which is 
based on the hypothesis that some biomarkers specific to asymmetric self-
renewal will also be specific to ASCs. A system that consists of cell lines 
engineered to recapitulate asymmetric self-renewal under experimental control45" 
47
, has been established. 
These cell lines are built from p53-null murine fetal fibroblasts. They are 
engineered to express normal levels of the wild-type p53 gene from a modified 
metallothionein promoter. In maintenance culture medium (i.e. Zn-free), the 
conditional p53 gene is off, and the cells undergo symmetric self-renewal. In 
ZnCI2-supplemented medium, normal levels of p53 protein are produced, and 
the cells switch to asymmetric self-renewal (Figure 3.2, p53-lnduced). In recent 
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p53-Null p53-lnduced p53-lnduced 
c-IMPDH II 
SYM ASYM 
Figure 3.2 Three engineered cell lines scheme for discovery 
of Asymmetric self-renewal associated (ASRA) bio-
molecules. 
P53-Null cell exhibits symmetric self-renewal (SYM). P53-lnduced 
cells exhibit asymmetric self-renewal (ASYM) in response to p53 
expression. C-IMPDH II expressing cells express p53 as well, but 
maintain symmetric self-renewal (p53SYM) 
gene expression profiling studies, the Sherley lab have shown that the 
asymmetric self-renewal state of the engineered cell lines has gene expression 
profiles similar to freshly isolated human ASCs (2009, Sherley, et al, unpublished 
data). The type II inosine-5'-monophosphate dehydrogenase(IMPDH II), a p53-
dependent down-regulation enzyme, was discovered to be necessary for 
asymmetric self-renewal by engineered cell lines. A congenic derivatives of the 
original p-53-inducible cell lines constitutivly expressed an IMPDH II transgenic 
cDNA ("c-IMPDH")4853. The c-IMPDH II lines retain Zn-inducible p53 expression, 
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but do not shift from symmetric self-renewal to asymmetric self-renewal ( scheme 
3.2. p53-lnduced c-IMPDH II) 46. Control p53-null cell lines were co-derived by 
stably transfecting the metallothionein promoter vector without a p53 cDNA 
insert. These lines retain symmetric self-renewal in Zn-supplemented medium 
(Scheme 3.2, p53-Null). 
In summary, the system includes three cell lines: p53-Null (SYM), p53-
Induced (ASYM), and p53-lnduced c-IMPDH II (p53SYM). Asymmetric self-
renewal associated biomolecules (ASRAs) are defined as those which are 
undetectable or produced at low levels in both SYM states, but show high level 
production in the ASYM state. The goal of the study is to identify those ASRAs 
Carbohydrate Biomarker Discovery of Adult Stem Cells 
As one of the three major biomacromolecule classes (protein, 
carbohydrate, and nucleic acid) in cells, carbohydrate plays critical roles in 
cellular activities. This naturally makes carbohydrate a good target candidate for 
biomarker discovery54"57. However, due to its structural complexity and the lack of 
efficient analytical tools, the space of carbohydrate biomarkers has remained 
unexplored. Over the past several years, an innovative integrated 
analytical/computational approach has been developed in the Reinhold lab at 
University of New Hampshire. This chapter summarizes the progress in exploring 
the glycoproteome for ASC-specific biomarkers using sequential mass 
spectrometry (MSn) technology. 
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3.2 Experimental Methods 
Sample preparation 
Three purified proteins (including glycoproteins) samples from three cell lines 
(SYM, ASYM, p53SYM) were provided by Dr. Sherley's Lab, Boston Biomedical 
Research Institute (BBRI). Previous samples treatment described as Dr. 
Sherley's Lab: 
Buffer used: 
100mM Ammonium Bicarbonate 
10mMEDTA 
No protease inhibitors were used 
Cell Extract: 
Trypsinize the cells and pellet the cells (neutralized the trypsin with 
media and washed twice with PBS) 
Add the above buffer 
Sonicate the cells and spin @ 4C 13,000rpm for 20min 
Collect the supernatant 
Protein by Bio-Rad DC protein Assay 
The samples were processed under identical conditions in parallel in our lab10: 
(1) N-linked glycans were released enzymatically by PNGase 
(2) N-linked glycans were collected by groups of neutral glycans and 
acidic glycans. 
(3) Glycans were reduced with a solution of sodium borohydride (NaBH4). 
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(4) Permethylation was carried out as described by Ciucanu and Kerek . 
(5) Reduced and permethylated glycans were re-suspended in a 75% (v/v) 
methanol aqueous solution for mass spectrometry analysis. 
Mass spectrometry 
The ion trap mass spectrometer instrument (LTQ, Thermo Fisher 
Scientific, Waltham, MA) was equipped with a TriVersa Nanomate® for automatic 
nanoelectrospray injection. Spectra were collected using Xcalibur 2.0 software 
(Thermo Fisher Scientific). Collision parameters were left at default values with 
normalized collision energy set at 35%. Activation Q was set at 0.25, and 
activation time was set at 30 ms. 
Data analysis 
In-house developed software was used to assist data analysis. A list of 
putative glycan ions and corresponding compositions were determined from MS 
profiles. An ion candidate pool was constructed and ranked based on the 
statistical significance of intensity fold-changes between samples and the signal 
intensity values. The top -50 ions were selected from MS profiles for further MSn 
experiments. A total of -1000 spectra were collected and analyzed in this study. 
The spectra with same MSn pathways were compared pair-wise among samples. 
The spectra-pairs with significant difference across samples were selected for 
further manual validation. The putative structures were then proposed based on 
glycan fragment compositions. 
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3.3 Results and Discussion 
A systematic differential N-glycome analysis was performed with the three 
cell lines using the sequential mass spectrometry techniques. For clarity, the 
results are organized into three subsections: (1) N-glycan MS profile comparison; 
(2) the discovery of the sample-specific glycan isomers; and, (3) the exploration 
of N-glycan branching patterns. 
3.3.1 N-glvcan MS profile comparison 
The ESI MS profiles of N-glycans from the three samples are shown in 
Figure 3.3. These three profiles have great similarities. However, the profiles still 
exhibit significant differences between three samples. The distribution of major 
N-glycans detected from MS profiles is summarized in Table 3.1. The relative 
abundances of N-glycans were calculated based on the most abundant peak m/z 
1115.9 (H8N2) from each profile. The base peak m/z 1115.9 is assigned with a 
relative abundance value of 100. The glycans with significant fluctuations in 
relative abundance across cell lines are highlighted by shaded rows. 
According to the synthetic process of N-linked glycans, the glycan 
compositions are divided into four groups 58"61. H10N2 to H7N2 (early processing 
stage); H6N2 to H2N2 (paucimannose forming stage); HxNy(y>3) (hybrid and 
complex forming stage); HxNyFI (fucosylation stage). Figure 3.4 is a bar 
diagram of the relative abundance distribution of HxN2 (x>7), HxN2(x<7), 
HxNy(y>3) and HxNyFI. 
-47-
Positive ion MS Profiles of SYM, ASYM, p53SYM 
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Figure 3.3: Comparative ESI-MS profiles analysis of reduced and methylated neutral N-
glycans from three engineered stem cell lines: SYM, ASYM and p53SYM. The peaks 
labeled with numbers are corresponding to N-glycans, Peaks labeled with a * are imp 
peaks (free glycans). 






































































































































































Table 3.1: The distribution of major N-glycans detected from MS profiles. The glycan 
compositions are grouped according to the synthetic process of N-linked glycans. The 
glycans with significant fluctuations in relative abundance across cell lines are 
highlighted by shaded rows. 
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Groups abundance distribution 
HxN2(x>7) | HxN2(2<x<7) 
High Mannose(HxN2) 
HxNy(y>3) 
Hybrid & complex 
HxNyFI 
Fucosylated 
Figure 3.4: The group abundance distribution of N-glycans across the three cell lines: 
SYM, ASYM, and p53SYM. 
For composition groups HxN2 (x>7), HxNy (y£3) and HxNyFI, it appears 
that there are no significant differences in these three samples. For example, in 
HxN2 (x>7), the relative abundance is 275.8, 270.8 and 263.8 in SYM, ASYM 
and p53SYM, respectively. However, for composition group HxN2(x<7), the 
relative abundances are significantly different in SYM, ASYM and p53SYM. In 
addition, for each composition, such as H2N2 and H3N2, the relative 
abundances in different samples are significantly different. 
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Figure 3.5: The major biosynthesis steps of N-glycans that localized in part of 
endoplasmic reticulum(ER) and Golgi apparatus of mammalian cells. The categories of 
N-glycans were divided into HxN2 (xS7), HxN2(x<7), HxNy(ys3), HxNyFI, according to 
the need of the data treatment. Modified from Herscovics A. 199958 
The comparison results of MS profiles clearly indicate that the N-glycan 
biosynthesis activities processed differently in the three cell lines. Figure 3.5 
shows the major biosynthesis steps of N-glycans that are localized in part of the 
endoplasmic reticulum (ER) and Golgi apparatus of mammalian cells. Various 
enzymes participate in each N-glycan synthetic step58. Among them, Golgi a-
Mannosidase IA, IB, IC and Golgi a-Mannosidase III are enzymes closely related 
to the differences of group of HxN2 (x<7) N-glycans based on profile comparison. 
Our results suggest that the enzyme activities and/or the gene expression levels 
of these related enzymes should be different in the three cell lines. This 
prediction can be verified by enzymetic activity assays and microarray 
experiments. 
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3.3.2 The discovery of the sample-specific qlvcan isomers 
Most of the around 1000 MSn spectra clllected showed great similarities 
between samples at every MSn level. This suggested that the three samples 
were highly correlated and the underlying structures were considerable similar 
between samples. However, isomeric structural differences have been detected. 
Here, the spectra and the structures identified within the ion m/z 1810.6+ served 
as an example for illustration purpose. 
In this study, the ion m/z 1810.6+ which corresponds to N-linked glycan 
composition H4N3F1, was selected as an example to illustrate the structural 
identification and differentiation process. 
The ion m/z 1810.6+ (H4N3F1) was isolated from each sample and 
processed on LTQ-MS. Table 3.2 shows the side by side comparison of MS" 
spectra of the samples. The ions that form diagnostic pathways were underlined 
in the spectra. The MSn spectra remain almost identical among samples until the 
MS4 / MS5 level. Table 3.3 summarizes five isomers identified from the ion m/z 
1810.6+ (H4N3F1) and their distributions within these three samples. The 
diagnostic pathways and corresponding glycan fragments are also shown in this 
table. 
Common structures shared by all three samples 
The structure S1 is defined by the pathway 1810 -> 1343 -> 880 -> 662 -> 
458 and 1810 -* 1343 -* 486 -> 268 (259). Although the relative intensities 
-52-
might be different, this pathway can be detected in all three samples. The 
structure S1 is the major glycan compound in all samples. 
The ion of m/z 1343 in MS2 spectrum corresponds to a neutral loss of 
reducing N with a terminal F attached. In MS3, the complement ions m/z 486 and 
880 were observed. The ion of m/z 486 suggests that one N and one H should 
bundle together as a terminal. However, it is not clear whether N or H is the 
terminal residue at this level. Further fragmentation of the ion m/z 486, MS4 (the 
notation MS4 is used here in order to differentiate it from another MS4 of H4N3F1 
fragments) generated the complement ions m/z 268 and m/z 259, which indicate 
terminal H and internal N, respectively. The ion m/z 880 (complementary to m/z 
486) was disassembled; the daughter ion m/z 662 in MS4 is the result of losing a 
terminal H. With the N-linked core structure constraint, the ion m/z 458 in MS5 
(neutral loss of internal H) finally defined the structure S1 in Table 3.3. 
Another common structure shared by the samples is determined as 
structure S2 (shown in Table 3.3). Its diagnostic pathway is 1810 -> 1343 -> 
1084 -> 880 -> 445. The neutral losses are: reducing N + terminal F (one scar), 
terminal N (one scar), internal H (two scars) and H+N with three scars, 
respectively. The leftover m/z 445 is terminal H2 dimer. With the constraint of the 
N-glycan core structure, the structure S2 can be unambiguously determined. 
Structure shared bv SYM and ASYM 
The pathway 1810 -> 1343 -^ 1084 -> 880 -> 676 can only be found in 
SYM and ASYM samples. The sequence of neutral losses corresponds to a loss 
- 5 3 -
of a reducing end N +terminal F (one scar), terminal N, internal H and another 
internal H, respectively. This indicates the sugar sequence of a branching arm 
should be N-H-H-. With the definition of N-glycan core structure, the structure S3 
is determined (as shown in Table 3.3). According to literature 2'58, and 59, this is not 
a usual structure corresponding to the major N-glycan biosynthesis. 
Structure shared by ASYM and P53SYM 
Similarly, the pathway 1810 -> 1343 -> 1084 -> 866-> 676 can be 
observed in the ASYM and p53SYM samples, but is not present in the SYM 
sample. The ion m/z 1084 in MS3 is the result of losing a terminal N; In MS4, the 
ion m/z 866 indicates the presence of another terminal H. The ion m/z 676 in 
MS5 is a loss of one H with three scars, which must be connected with the early 
neutral loss of terminal N and H. The structure S4 can be defined by this 
diagnostic MSn pathway. 
ASMY specific isomer 
In the MS5 spectrum of the pathway 1810 -> 1343 -> 1084 -» 866, the ion 
m/z 444 and m/z 463 are found in the ASYM sample only, but undetectable in the 
SYM and p53SYM samples, as shown in Table 3.2. The ion m/z 1084 in MS3 and 
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Table 3.2 Side by side comparison of MSn spectra obtained from three cell lines within 
the ion m/z 1810.6+ (H4N3F1). The ions corresponding to the diagnostic pathways are 
highlighted in the spectra. 
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Table 3.3: The distribution of the isomers identified within the ion m/z 1810.6+ (H4N3F1). 
The diagnostic pathways and the corresponding glycan fragments are labeled in the 
diagram. (++: present as a major compound; +: present; -: undetected) 
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the ion m/z 866 in MS4 indicate there should be a terminal N and a terminal H 
lost. The ions m/z 444 and 463 in MS5 are complement fragments. This suggests 
the presence of another terminal dimmer H2. By using the N-linked core 
constraint, and putting all the residues together, the structure S5 can be derived 
with minimal ambiguity. This ASYM-specific glycan structure is qualified to be 
considered as a candidate of the asymmetric self-renewal associated bio-
molecules (ASRAs). 
3.3.3 The exploration of N-qlvcan branching patterns 
By investigation of a large N-glycans pool, not only ASYM specific N-
glycans were revealed, but also different kinds of structural abundance trends 
were discovered among three different cell lines. 
Most of the spectra corresponding to each composition from different 
samples display a very similar cleavage pattern. However, the quantitative 
differences between each sample are still present. This quantitative difference 
appears trivial and useless when analyzed separately. However, after data 
collection and re-arrangement, the trend of certain glycosilation patterns was 
discovered. The ability of LTQ instrument quantitative definition has not been 
qualified. However, this relative quantity comparison might lead to the discovery 
of glycosylation mechanisms or enzyme functions. 
-57-
Structure templates 
To understand the pattern of structures in each category, three templates 
were set up based on the structures that we investigated. Figure 3.6 shows the 
proposed structural templates. They do not include any specific linkages. These 
templates may reflect different functions of various GlcNAc-transferases among 
samples. 
Template 1 represents the type of N-glycan structures with following 
features: one N was attached to the core 1-3 (or 1-6) arm Mannose and no N 
was attached to the inner core Mannose; the other arm could be N or NH dimer 
attached or no other residues attached; the reduced terminal N could be 
fucosylated or not. The core fragments from stage MSn spectra with m/z 662 and 
MSn+1 spectra with m/z 458 reflect the abundance of structures of this category. 
^ J HexNAc ( J Hexose R 1 could be none or Fucose R 2 could be none, HexNAc, or NH dimer 
Figure 3.6 Structural templates. The linkages were not specified. 
Template 2 represents the type of N-glycan structures with following 
features: one N attached to the inner core Mannose; one arm could be attached 
by N, NH or no attachment and no attachment on the other arm; the reduced 
-58-
terminal N could be fucosylated or not. The core fragments from stage MSn 
spectra with m/z 662 and MSn+1 spectra with m/z 444 reflect the abundance of 
structures of this category. 
Template 3 represents the type of N-glycan structures with following 
features: there is a branch on one core arm- one N and another N (or NH dimer) 
attached to this arm; no attachment to the other arm; the reduced terminal N 
could be fucosylated or not. The core fragments from certain stage MSn spectra 
with an m/z value of 676 will reflect the abundance of structures of this category. 
Structures relative abundance distributions 
A total of 28 N-glycan compositions were investiagated for the detailed 
structures. Based on the proposed templates, data of those fitting structures 
were collected from specific peaks of certain stage MSn spectra to get the relative 
abundances of each categorical structures. Data obtained from each structure 
were taken from the corresponding spectra of three samples at the same 
condition. By analyzing these data, two structural trends were found. 
Trend 1: Table 3.4 shows relative isomeric abundances of 5 compositions 
collected from characteristic signature ions. For example, m/z 458 was selected 
for Template 1, and m/z 444 was selected for the structure of Template 2. The 
corresponding fragmentation pathway for signature ions of each composition is 
also shown in the table. The measurement of relative abundance of each ion is 
based on the signature ion m/z 458 of Template 1, i.e., the relative abundance 
or ratio of the ion m/z 458 is 100%. The last three columns of Table 3.5 are 
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Table 3.4 Compar ison of structural isomers (Template 1 and Templa te 2) distr ibut ion in 
each composi t ion of samples: S Y M , A S Y M , p53SYM. 
The structural abundance ratios of Template 2 versus Template 1 show a 
trend among the samples. It is shown that SYM and ASYM cell lines have similiar 
"tendancy" to form Template 2 style of structures. The tendancy appears much 
stronger than that of p53SYM. This trend might be an indicator (s) of functions of 
different cells, and / or the relative strengths of corresponding enzymes. 
Significant differences of structural distribution are observed in a particular 
composition. For example, H4N4F1 has a relative abundance ratios of 21%, 23% 
and 2.4% in SYM, ASMY and P53SYM, respectively. This might be used as a 
biomarker to identify and isolate cells of p53SYM from other cells. Figure 3.7 
shows the structural distributions of three samples for different compositions. 
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H3N3 H3N3F1 H3N4 H3N4F1 H4N4F1 
Figure 3.7 Comparison of relative abundance of Template 2 structures versus Template 1 
structures among sample SYM, ASYM and p53SYM. 
Trend 2: Table 3.5 lists the relative abundances of 5 compositions from 
Template 3 and Template 1 and 2. The fragmentation pathways for each 
composition of each ion are shown in Table 3.6. Similarly, the relative 
abundances were calculated by ratioing the abundance of each composition with 
the abuandance of the characteristic signature ion. In this case, the ion of m/z 
662 was selected for the structures of Template 3, and the ion of m/z of 676 was 
selected for Template 1 and 2. The last three columns of Table 3.5 are the 
relative abundances of structures of Template 3 for each composition. 
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Table 3.5 A comparison of structural isomers (Template 3 vs. Template 1+2) distribution in each 
composition among samples: SYM, ASYM, p53SYM. 
The structural abundance ratios of Template 3 to Template 1 and 2 are 
quite different in different samples. SYM always has a lower abundance of 
Template 3 structures than ASYM and p53SYM. For some specific compositions, 
such as H4N4F1, H3N5F1 and H5N5F1, the differences are fairly big. These 
differences might be used as biomarkers to identify and isolate different stem 
cells. Figure 3.8 shows the structural distributions of three samples for different 
compositions. 
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H3N4 H3N4F1 H4N4F1 H3N5F1 H5N5F1 
Figure 3.8 Comparison of relative abundance of Template 3 structures versus Templatel + 2 
structures among sample SYM, ASYM and p53SYM. 
Different GlcNAc transferases have been isolated and characterized in N-
glycans branching of animal cells (Figure 3.9). For identical substrates, the 
glycosyltransferases compete on given N-glycans to make the products varied2' 
60-64 -pnjS m j g n t be t n e r e a s o n for different structural distributions of these three 
samples. GlcNAc T-lll appears more competitive in sample SYM and sample 
ASYM than in p53SYM. Meanwhile, GlcNAc T-VI and GlcNAc T-V exhibits 
weaker strengths in sample SYM, than in sample ASYM and sample p53SYM. 





core Pwcf QBP-A. 
As** 
Figure 3.9 UDP-GlcNAc transferases in N-glycan branching and the GDP-a1-6 
fucosyltransferase involved in core fucosylation in animal cells. This figure is adapted from 
Essential of Glycobiology. 
3.4 Conclusion 
Most of the spectra were similar between samples at every MSn level. This 
suggested that the three samples were highly correlated and the underlying 
glycan structures were considerably similar. However, not only composition 
differences but also isomeric structural differences were detected. For 
composition group HxN2(x<7), the relative abundances are significantly different 
in SYM, ASYM and p53SYM; within the ion m/z 1810.6+ (H4N3F1) five distinct 
isomers were determined: two structures are shared by all three samples; one is 
shared by SYM and ASYM states; one is shared by ASYM and p53SYM states; 
and one isomer is characterized as ASYM-specific, for it is undetectable in both 
SYM states, but present in the ASYM state. This ASYM-specific glycan structure 
S5 could be considered a candidate biomarker for asymmetric self-renewal 
(ASRAs). 
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Importantly, these data again demonstrate that isomeric differences are 
often not exposed until MS3 through MS5. And, as such, these data strongly 
suggest that routine tandem MS (i.e. MS2) in many cases would be incapable of 
defining these differences. MS", when coupled with appropriate sample 
preparation, however appears uniquely capable of not only identifying this 
complexity, but fully characterizing each structural difference in the absence of 
time consuming chromatographic efforts. This makes MSn technology an 
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(To be continued) 
Table: Summary information of topology and linkages determination for each composition by MSn. 
Comparison structures reported by documents also was included. 
Notes: 
1. The topology isomers listed didn't involve linkages information. The linkage isomers gave the full or 
partial details of linkage information depending on sample abundance, isomer structure and necessity. The 
linkages were labeled if enough evidences were spotted. The path way used in topology detection may be 
changed for the linkage determination by demands 
-66-
2. References structures information involved two papers (reference 28&31). The structures from 
reference31 may be involved the linkages clarified without notification. The structures from reference28 
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(To be continued) 
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